UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001432 |
|---|---|
| Receipt number | R000001708 |
| Scientific Title | Evaluation of difluprednate ophthalmic emulsionfor macular edema and neovascular desease |
| Date of disclosure of the study information | 2010/09/30 |
| Last modified on | 2021/03/20 10:54:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/10/16 13:57:24 | ||
| 2 | Update | 2009/01/20 20:50:32 | Recruitment status |
|
| 3 | Update | 2010/07/04 15:26:12 | Recruitment status |
|
| 4 | Update | 2010/10/26 18:13:00 | Publication of results Results Results |
|
| 5 | Update | 2011/06/22 15:28:49 | Name of person sending information Name of person sending information Organization Organization Division name Address Email1 |
|
| 6 | Update | 2011/10/17 08:29:46 | Results Results |
|
| 7 | Update | 2013/12/02 09:18:13 | Other related information |
|
| 8 | Update | 2015/07/08 17:09:43 | Last follow-up date |
|
| 9 | Update | 2019/10/25 15:25:25 | Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 10 | Update | 2019/10/25 15:34:14 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
| 11 | Update | 2019/10/25 15:44:21 | Recruitment status Date of IRB |
|
| 12 | Update | 2021/03/20 10:41:27 | Recruitment status Date analysis concluded Other related information |
|
| 13 | Update | 2021/03/20 10:51:02 | Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD |
|
| 14 | Update | 2021/03/20 10:54:00 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
